Skip to main content

Socioeconomic and Environmental Drivers of Pediatric Malaria

March 30, 2026
Ashley Wade is a medical student at Icahn School of Medicine at Mount Sinai and is mentored by Ross Boyce, MD, MSc. In many parts of Sub‑Saharan Africa, malaria is still one of the main reasons children are hospitalized. In a recent study, Wade and Annika Gunderson, a UNC Epidemiology...

Tracking Respiratory Infections in People Living With HIV in Rural Uganda

March 19, 2026
Lauryn Ursery is a PhD student in epidemiology studying at the Gillings School of Global Public Health, mentored by Dr. Ross Boyce. In rural Western Uganda, people living with HIV face unique health risks, including viral acute respiratory infections (ARIs) such as the flu. Ursery presented a study led by...

Tracking Zika and Dengue: Insights into Maternal and Infant Immunity in Nicaragua

March 12, 2026
Omar Zepeda is a PhD student studying at the University of Costa Rica and a fellow of the Nicaraguan Emerging and Endemic Diseases (NEED) program. He is mentored by Filemon Bucardo, PhD. At the recent 4th Annual Global Health Symposium Zepeda presented his findings on the Zika and Dengue viruses...

Zambia Scholars Drive New Insights in Neurological Health

March 11, 2026
At this year’s Global Health Scholars Symposium, students and early‑career researchers showcased a powerful range of studies addressing urgent neurological and health systems challenges in Zambia. The event was sponsored by the Institute for Global Health and Infectious Diseases and the Gillings School of Global Public Health. Neurologist Monica Diaz,...

Exploring the Link Between Gold Mining and Malaria in Tanzania

March 11, 2026
Claudia Gaither is a PhD student in Epidemiology studying at the Gillings School of Global Public Health, mentored by Michael Emch, PhD. At the 4th Annual Global Health Scholars Symposium, Gaither talked about the relationship between malaria prevalence and proximity to mineral processing pits in northwestern Tanzania, where gold mining...

UNC Project-China Examines Factors Shaping Prosocial Behavior in Donation‑Based HIV/STI Interventions

March 5, 2026
A systematic review led by Dorian Ho (UNC BSPH-2025), and Joseph Tucker, co-director of UNC Project-China and a member of the UNC Institute for Global Health and Infectious Diseases, found that givers leveraged altruism, agency, and relationality with recipients to improve distribution and use of health services in their social...

Gay Leads New Frontier in HIV Cure Science 

March 4, 2026
Cindy Gay, MD, MPH, and David Margolis, MD, and the UNC HIV Cure Center have launched two ambitious studies that are poised to advance HIV Cure science closer to ending the epidemic. The first uses highly engineered antibody-like molecules to help the immune system find and clear HIV‑infected cells, uniting...

Case Study Highlights Critical Need for Third‑Trimester Syphilis Screening in Carceral Settings to Prevent Congenital Syphilis 

March 2, 2026
Chapel Hill, NC— A newly published case study in the Journal of Correctional Health Care urges immediate action to strengthen syphilis screening protocols for pregnant individuals in U.S. jails and prisons. Researchers at the Institute for Global Health and Infectious Diseases recently published “Syphilis Screening Among Pregnant Individuals in Carceral...

Key International Mpox Trial Finds No Clinical Benefit from Tecovirimat 

February 26, 2026
William A. Fischer II, MD, Director of Emerging Pathogens at UNC’s Institute for Global Health and Infectious Diseases and Joe Eron, MD, UNC Chief of Infectious Diseases and chair of the ACTG, co-authored a study that found tecovirimat used to treat mpox does not shorten time to lesion resolution, reduce...

Twice‑Yearly Injectable HIV Regime Treatment Demonstrates Strong Efficacy and Safety  

February 26, 2026
A trial led by Joe Eron, MD, a researcher with the UNC Institute for Global Health and Infectious Diseases, marks a significant milestone toward what could become the first complete long‑acting HIV regimen requiring dosing only twice per year. This new report is considered the first Phase 2 study to...

Study Warns of Underrecognized Lassa Fever Threat with Global Implications

January 27, 2026
Chapel Hill, NC—A new study led by researchers at the Institute for Global Health and Infectious Diseases at the University of North Carolina School of Medicine in Chapel Hill shows an urgent need for improved detection and treatment of Lassa fever, published in The Lancet Infectious Diseases. Lassa fever–a severe...

New Once Weekly Investigational Oral Regimen Shows Strong 48 Week Results, Highlighting the Need for Easier HIV Treatment Options

January 16, 2026
Chapel Hill, N.C. — A Phase 2 study led by Dr. Joe Eron, a member of the UNC Institute for Global Health and Infectious Diseases, shows an investigational once‑weekly, all‑oral combination of islatravir (ISL) and lenacapavir(LEN) maintains high levels of virologic suppression through 48 weeks in adults living with HIV....